(Z)-2-(2-aminothiazol-4-yl)-N-((5aR,6R)-1,7-dioxo-1,3,4,5a,6,7-hexahydroazeto[2,1-b]furo[3,4-d][1,3]thiazin-6-yl)-2-(methoxyimino)acetamide;[5aR-[5a?,6?]]-2-Amino-?-(methoxyimino)-N-(1,4,5a,6-tetrahydro-1,7-dioxo-3H,7H-azeto[2,1-b]furo[3,4-d][1,3]thiazin-6-yl)-4-thiazoleacetamide;Cefotaxime Sodium EP Impurity E;3-Desacetyl Cefotaxime Lactone (E/Z Mixture)
Cefotaxime EP Impurity E is a fully characterized chemical compound used as a reference standard of API Cefotaxime. The standard offered is compliant with regulatory guidelines. Cefotaxime EP Impurity E is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 66340-33-8
Related products
Cefotaxime EP Impurity D Sodium Salt
M.F. C₁₆H₁₆N₅O₇S₂. Na
M.W. 454.46 22.99
CAT# AR-C01908
CAS# 65715-12-0
Cefotaxime EP Impurity F (Cefotaxime Dimer)
M.F. C₃₀H₃₀N₁₀O₁₂S₄
M.W. 850.87
CAT# AR-C01916
CAS# 175032-97-0
